Saturday, April 18, 2026

This Vitamin May Reduce Colon Cancer Risk by 58%, New Study Suggests

Key Takeaways

 A new study suggests that higher vitamin D levels may lead to lower rates of colon cancer.

Eating patterns like the Mediterranean diet tend to include higher levels of vitamin D.

Chat with your doctor to decide if vitamin D supplement is a good choice for you.

 

Colorectal cancer is one of the leading cancers worldwide, especially in countries that follow a Western lifestyle and diet.  Worldwide, 1.2 million new colorectal cancer cases are diagnosed each year, making it the second most common cancer in men and the third most common in women. 

In the U.S., colorectal cancer—sometimes called CRC—is the third most common cancer diagnosed in men and women, excluding skin cancers. The lifetime risk for developing colorectal cancer is about 1 in 24 for men and 1 in 26 for women, depending on risk factors.

Scientists are always looking for ways to reduce the risk of diseases like colorectal cancer, which includes cancers of the colon and rectum. In a review of previously published studies, researchers focused on the relationship between vitamin D and colorectal cancer. They published the review in April 2025 in Nutrients.1 Let’s break down their findings.

How Was This Study Conducted?

This study was a review, meaning that the researchers assessed a variety of previous studies to look for overarching connections the results shared.

Researchers searched scientific databases for studies on colorectal cancer and vitamin D. While they initially found over 10,000 studies, they ended up with 50 after sifting through them and removing duplicates and those that didn’t meet their criteria. 

Specifically, the researchers only wanted to include studies in adult human participants who either had colorectal cancer (or precursors for colorectal cancer) or had a documented vitamin D deficiency. They also sought out cases where participants were given a vitamin D supplement as part of the study.

What Did It Show?

According to these researchers, vitamin D has been shown to have many benefits in our bodies, including supporting communication between nerve cells, regulating blood pressure and preventing respiratory infections. It plays roles in maintaining gut health, thyroid hormone levels, blood sugar levels and even mitigating the harmful effects of aging. Vitamin D also acts as an antioxidant, reducing inflammation, suppressing autoimmune responses and supporting the function of immune cells.

The researchers also cite a previous study that suggests that vitamin D inhibits uncontrolled cell growth and the formation of new blood vessels that “feed” cancer cells (called angiogenesis) and promotes apoptosis (killing abnormal cells).

So what did these researchers find regarding vitamin D and colorectal cancer? While there was some conflicting evidence, they state that vitamin D deficiency is strongly linked to an increased risk of colorectal cancer, partly because that deficiency exacerbates intestinal inflammation, which promotes colorectal cancer progression.

Specifically, one meta-analysis of 31 original studies reported that compared to people with the lowest dietary intake of vitamin D (10 ng/mL), those with the highest amount (80 ng/mL) showed a 25% reduction in colorectal cancer risk. 

The Nurses’ Health Study, a large long-term U.S. study commonly used to find connections between lifestyle factors and disease risk, showed that women with the highest vitamin D intake had a 58% reduced risk of colorectal cancer compared to those with the lowest intake. 

The Iowa Women’s Health Study found that those with the highest calcium and vitamin D intake reduced their risk of colorectal cancer by about half. The Spanish PREDIMED study had similar results, as did studies that used vitamin D supplementation (as opposed to getting it through food). 

Polyps and adenomas are precursors to colorectal cancer and are commonly found and removed during colonoscopies. Researchers found evidence that vitamin D can also help prevent polyps. For example, a Canadian study with 1,409 participants found that vitamin D supplementation reduced the probability of polyp development by 33% and the risk of high-risk adenomatous polyps by 43%. 

Overall, researchers found that vitamin D, both dietary and supplemented, plays a crucial role in preventing and treating colorectal cancer by reducing inflammation, regulating immune responses, promoting cancer cell death and inhibiting tumor growth. For those who have colorectal cancer, vitamin D may help promote better survival rates and reduce death rates from colorectal cancer. 

There were a few limitations to this review. First, though many studies showed protective benefits of vitamin D on colorectal cancer, most could not define the mechanisms through which these benefits occurred. Study authors also state that more large-scale, randomized clinical trials need to be done, which will provide more answers, including optimal dosage and formulations of vitamin D supplements. 

How Does This Apply to Real Life?

Based on the evidence in this review, vitamin D appears to help prevent colorectal cancer and may help people with colorectal cancer survive it. Unfortunately, vitamin D is a commonly deficient vitamin. Worldwide, vitamin D deficiency is estimated to range from 30% to 50%, with even higher rates seen in specific populations.3

Risk factors for vitamin D deficiency include being a woman, living in regions that experience colder winter climates, having darker skin and living in a low- and middle-income country where proper nutrition and supplements may be more limited. 

Besides having a genetic predisposition for colorectal cancer, other risk factors include older age, sedentary lifestyle and a diet high in unhealthy fats and red meat and low in fiber. An imbalanced gut microbiome also plays a role, as do having inflammatory bowel disease, obesity, frailty and diabetes. 

Vitamin D is called the sunshine vitamin because your body manufactures it with exposure to UVB rays—aka sunshine. But if you live in a region that experiences cold winters, it can be difficult or impossible to get enough sun exposure during those months. In the warmer months, you should consider your skin cancer risk and balance it with sun exposure. You also need to have enough skin exposure to make vitamin D—face, arms and legs. Plus, pollution, darker skin and possibly sunscreen reduce sunlight absorption, reducing vitamin D production. For these reasons, diet and supplementation may be more reliable avenues for getting enough vitamin D. 

Because it is possible to overdo it and end up with vitamin D toxicity, before you start putting the vitamin D supplements to use, it helps to know your blood levels. This can be done by requesting a blood test from your primary care practitioner. If you end up being deficient, meeting with a registered dietitian can help you figure out what foods and how much of each you need to eat each day to get your levels up. A registered dietitian (RD) can also help you supplement, if that is your desire or if it’s recommended. 

Another finding from this review was that healthy eating patterns, like the Mediterranean diet, tend to be plentiful in vitamin D and other anti-inflammatory nutrients. The Mediterranean diet is rich in fruits, vegetables, nuts, seeds, whole grains, fish, dairy and healthy fats. While there aren’t a lot of food sources of vitamin D, ones that contain it include egg yolks, fatty fish (like salmon, tuna, mackerel and sardines) and some mushrooms. Fortified dairy products and orange juices also contain vitamin D. Researchers note that a holistic dietary approach may be a better strategy than focusing on one isolated nutrient. 

The Bottom Line

This review of 50 studies found a strong connection between adequate vitamin D levels and a reduced risk of colorectal cancer.1 Because vitamin D deficiency is so common, it can be helpful to have blood work to test your levels. Based on the results, if you need to increase your levels, try adding foods rich in vitamin D, including whole eggs, salmon, mushrooms and fortified dairy products, like milk and yogurt, to your diet. Following a healthy eating pattern, like the Mediterranean diet, can also be beneficial.

If you choose to supplement, work with a registered dietitian or your primary care practitioner to determine the best dose for you. When possible, spend time outside to catch some rays. Being outdoors also has mental health and mood benefits—all the better if your physical activity is performed outside.

 

 

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

 

Labels: , , , , ,

Tuesday, January 16, 2018

Dietary Fat Metabolism May Promote Metastasis

Prostate tumours tend to be what scientists call “indolent” – so slow-growing and self-contained that many affected men die with prostate cancer, not of it. But for the percentage of men whose prostate tumours metastasize, the disease is invariably fatal. In a set of papers out today in the journals, researchers shed new light on the genetic mechanisms that promote metastasis in the mouse model and implicated the typical Western high-fat diet as a key environmental factor driving metastasis.

“Although it is widely postulated that a Western diet can promote prostate cancer progression, direct evidence supporting a strong association between dietary lipids and prostate cancer has been lacking,” said first author.

Epidemiological data links dietary fats (and obesity) to many types of cancer, and rates of cancer deaths from metastatic cancers including prostate cancer are higher in the United States than in nations where lower fat diets are more common. While prostate cancer affects about ten percent of men in Asian nations, that rate climbs to about 40 percent when they immigrate to the U.S., mirroring the rates among the native-born U.S. population. That points to an environmental culprit that may combine with genetic factors to drive this aggressive, fatal disease.

“The progression of cancer to the metastatic stage represents a pivotal event that influences patient outcomes and the therapeutic options available to patients,” said the senior author. “Our data provide a strong genetic foundation for the mechanisms underlying metastatic progression, and we also demonstrated how environmental factors can boost these mechanisms to promote progression from primary to advanced metastatic cancer.”

The tumour suppressor gene PTEN is known to play a major role in prostate cancer; its partial loss occurs in up to 70 percent of primary prostate tumours. Its complete loss is linked to metastatic prostate disease, but animal studies suggest the loss of PTEN alone is not enough to trigger progression. The researchers sought to identify an additional tumour suppressing gene or pathway that may work in concert with PTEN to drive metastasis.

Looking at recent genomic data, the team noticed that another tumour suppressor gene, called PML, tended to be present in localized (non-metastatic) prostate tumours, but was absent in about a third of metastatic prostate tumours. Moreover, about 20 percent of metastatic prostate tumours lack both PML and PTEN.

When they compared the two types of tumour – the localized ones lacking only the PTEN gene versus the metastatic tumours lacking both genes – the researchers found that the metastatic tumours produced huge amounts of lipids, or fats. In tumours that lacked both PTEN and PML tumour suppressing genes, the cells’ fat-production machinery was running amok.

“It was as though we’d found the tumours’ lipogenic, or fat production, switch,” said the Dr. “The implication is, if there’s a switch, maybe there’s a drug with which we can block this switch and maybe we can prevent metastasis or even cure metastatic prostate cancer,” he added.

Such a drug already exists. Discovered in 2009, a molecule named “fatostatin” is currently being investigated for the treatment of obesity. The researchers tested the molecule in lab mice. “The obesity drug blocked the lipogenesis fantastically and the tumours regressed and didn’t metastasize.”

In addition to opening the door to new treatment for metastatic prostate cancer, these findings also helped solve a long-standing scientific puzzle. For years, researchers had difficulty modelling metastatic prostate cancer in mice, making it hard to study the disease in the lab. Some speculated that mice simply weren’t a good model for this disease. But the lipid production finding raised a question in the Dr.’s mind.

“I asked, ‘What do our mice eat?’” the Dr. recalled.

It turned out, the mice ate a vegetable-based chow – essentially a low-fat vegan diet that bore little resemblance to that of the average American male. When the researchers increased the levels of saturated fats – the kind found in fast food cheeseburgers and fries – in the animals’ diet, the mice developed aggressive, metastatic tumours.

The findings could result in more accurate and predictive mouse models for metastatic prostate cancer, which in turn could accelerate discovery of better therapies for the disease. Additionally, physicians could soon be able to screen their early-stage prostate cancer patients for those whose tumours lack both PTEN and PML tumour suppressing genes, putting them at increased risk for progressing to metastatic disease. These patients may be helped by starving these tumours of fat either with the fat-blocking drug or through diet.

“The data are tremendously actionable, and they surely will convince you to change your lifestyle,” the Dr. said.

THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES.    
 
PS- THOSE INTERESTED IN RECIPES ARE FREE TO VIEW MY BLOG-                      
HTTP:GSEASYRECIPES.BLOGSPOT.COM/
FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG-                                                                       
HTTP://KNEE REPLACEMENT-STICK CLUB.BLOGSPOT.COM/
FOR CROCHET DESIGNS

HTTP://MY CROCHET CREATIONS.BLOGSPOT.COM


Labels: , , , , , , , , , , , ,